Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 53 out of 100. Digital health tools

Topic: Risk, prevention and care in population studies

Both ML short forms showed high internal consistency (α = 0.96 for ML-WHODAS-16 and 0.93 for ML-WHODAS-10) and excellent concurrent validity with the full WHODAS-32 (r = 0.98 for both). Compared with the Standard-12, they showed lower error, negligible Bland-Altman bias, and met predefined equivalence criteria, including ±0.5 points. Anchor-based Responsiveness was broadly comparable to the Disability Severity Grade (anchor) (r = 0.66-0.67; standardized response mean = 0.37-0.40). Anchor-based minimal clinically important differences were 9.26 for ML-WHODAS-16 and 9.95 for ML-WHODAS-10. The ML-WHODAS-16 and ML-WHODAS-10 substantially reduced assessment burden while maintaining scores that closely reflected those of the full WHODAS-32, particularly for group-level assessment and longitudinal monitoring. These findings support their use as practical, low-burden alternatives in dementia disability assessment. However, external validation, validation against harder clinical outcomes, formal non-inferiority testing, and clinically anchored longitudinal thresholds remain needed before individual-level interchangeability can be inferred.

Key findings

Why it matters

This study developed shorter machine learning versions of a disability assessment questionnaire for people with dementia that closely reflect the full version while reducing assessment burden. It concerns measurement of disability, not the treatment, cure or prevention of Alzheimer's disease, and the authors note external validation is still needed.

Study details

How this study scored 53/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 1 of 4; Study design 7 of 12; Strength of evidence 3 of 5; Peer-review validation 10 of 10; How recent 5 of 5; Sample size 4 of 4; Effect reported 0 of 3; Studied in people 3 of 3; Randomised / blinded 0 of 2; Times cited 1 of 7; Citations per year 0 of 5; Impact for its field and year 3 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record left out, no data; Institution's track record 1 of 3; Multi-centre collaboration 2 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. 51 of the 96 points it could be judged on, which is 53 of 100. Total 53 of 100.51 of the 96 points we could judge = 53 of 100

Published in a peer-reviewed journal, and it is a longitudinal study following the same people over time. Scored zero for effect reported and randomised / blinded because the record does not state it. We have no data on senior author's track record, so that was left out: it earned 51 of the 96 points we could judge it on, which is 53 out of 100.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Journal of the Formosan Medical Association)
Journal's citation record 1 / 4 Journal of the Formosan Medical Association: journal h-index 87 (OpenAlex, 2026-10-29)
Study design 7 / 12 A longitudinal study following the same people over time
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 4 / 4 31,952 participants
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 1 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.5 citations a year over 2 year(s) since 2026
Impact for its field and year 3 / 6 Cited 4.7× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record — / 4 Senior author's record not available — left out of this score
Institution's track record 1 / 3 National Taiwan University: institution h-index 752 (OpenAlex)
Multi-centre collaboration 2 / 3 OpenAlex lists 6 institution(s) in 1 country
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 42069499)
Free to read 2 / 2 Free to read
Points 51 / 96 Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 51 of the 96 points we could judge it on is 53 out of 100.
Total 53 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

APA 7th

Lin, G., Wang, Y., Lee, S., Chi, W., Liu, J.-H., & Hsieh, C. (2026). Developing machine learning-enhanced WHODAS 2.0 short forms for persons with dementia. Journal of the Formosan Medical Association. https://doi.org/10.1016/j.jfma.2026.04.085

Vancouver

Lin G, Wang Y, Lee S, Chi W, Liu J.-H, Hsieh C. Developing machine learning-enhanced WHODAS 2.0 short forms for persons with dementia. Journal of the Formosan Medical Association. 2026. doi:10.1016/j.jfma.2026.04.085. PMID: 42069499.

BibTeX

@article{lin2026-42069499,
  author  = {Lin, Gong‐Hong and Wang, Yi‐Ching and Lee, Shih‐Chieh and Chi, Wen‐Chou and Liu, Jen-Hsuan and Hsieh, Ching‐Lin},
  title   = {{Developing machine learning-enhanced WHODAS 2.0 short forms for persons with dementia}},
  journal = {Journal of the Formosan Medical Association},
  year    = {2026},
  doi     = {10.1016/j.jfma.2026.04.085},
  pmid    = {42069499},
  url     = {https://doi.org/10.1016/j.jfma.2026.04.085}
}

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Digital health tools

Similar studies

More on Digital health tools

See all studies in Digital health tools →